Nicole CoustierDiscover why payer dossiers are critical for MedTech startups, even in early stages. Learn how they guide evidence development, coding, and reimbursement strategy.
Nicole CoustierOne study rarely unlocks full payer coverage. Learn why U.S. market access requires a portfolio of evidence, strategic sequencing, and payer-specific insights.
Nicole CoustierA clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.
Nicole CoustierQALYs are essential in Europe—but not in the U.S. Here's what really drives MedTech coverage decisions and how to pivot.
Nicole CoustierLearn how payer claims data strengthens medtech value stories without long clinical trials.
Nicole CoustierWhy do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.